[HTML][HTML] Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis
BJ Langford, M So, S Raybardhan, V Leung… - Clinical microbiology …, 2021 - Elsevier
Background The proportion of patients infected with SARS-CoV-2 that are prescribed
antibiotics is uncertain, and may contribute to patient harm and global antibiotic resistance …
antibiotics is uncertain, and may contribute to patient harm and global antibiotic resistance …
Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis
JS Musuuza, L Watson, V Parmasad… - PloS one, 2021 - journals.plos.org
Introduction The recovery of other pathogens in patients with SARS-CoV-2 infection has
been reported, either at the time of a SARS-CoV-2 infection diagnosis (co-infection) or …
been reported, either at the time of a SARS-CoV-2 infection diagnosis (co-infection) or …
[HTML][HTML] COVID-19 and comorbidities: Deleterious impact on infected patients
The pandemic situation with the emergence of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) from China has endangered human lives. Coronavirus …
coronavirus 2 (SARS-CoV-2) from China has endangered human lives. Coronavirus …
Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing
Background To explore and describe the current literature surrounding bacterial/fungal
coinfection in patients with coronavirus infection. Methods MEDLINE, EMBASE, and Web of …
coinfection in patients with coronavirus infection. Methods MEDLINE, EMBASE, and Web of …
Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
As a zoonotic disease that has already spread globally to several million human beings and
possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID‐19) …
possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID‐19) …
The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from …
MC Grant, L Geoghegan, M Arbyn, Z Mohammed… - PloS one, 2020 - journals.plos.org
Background To limit the spread of SARS-CoV-2, an evidence-based understanding of the
symptoms is critical to inform guidelines for quarantining and testing. The most common …
symptoms is critical to inform guidelines for quarantining and testing. The most common …
Smoking is associated with COVID-19 progression: a meta-analysis
R Patanavanich, SA Glantz - Nicotine and tobacco research, 2020 - academic.oup.com
Introduction Smoking depresses pulmonary immune function and is a risk factor contracting
other infectious diseases and more serious outcomes among people who become infected …
other infectious diseases and more serious outcomes among people who become infected …
The genetic sequence, origin, and diagnosis of SARS-CoV-2
H Wang, X Li, T Li, S Zhang, L Wang, X Wu… - European Journal of …, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is a new infectious disease that first emerged in …
syndrome coronavirus 2 (SARS-CoV-2), is a new infectious disease that first emerged in …
The conundrum of 'long-COVID-19: a narrative review
COVID-19 is an ongoing pandemic with many challenges that are now extending to its
intriguing long-term sequel.'Long-COVID-19ʹ is a term given to the lingering or protracted …
intriguing long-term sequel.'Long-COVID-19ʹ is a term given to the lingering or protracted …
The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta …
Aims To estimate the association of smoking status with rates of (i) infection,(ii)
hospitalization,(iii) disease severity and (iv) mortality from SARS‐CoV‐2/COVID‐19 disease …
hospitalization,(iii) disease severity and (iv) mortality from SARS‐CoV‐2/COVID‐19 disease …